当前位置:首页 - 行情中心 - 美康生物(300439) - 财务分析

美康生物

(300439)

  

流通市值:30.17亿  总市值:39.66亿
流通股本:2.92亿   总股本:3.84亿

美康生物(300439)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.56亿元,每股收益0.15元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益294524.39万元,未分配利润132872.83万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产365527.38万元,负债71003.00万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入736,221,523.12374,030,860.651,742,424,499.511,406,709,821.37
营业总成本706,593,829.78350,212,593.711,525,930,374.421,191,514,043.79
其他经营收益
营业利润54,601,857.1834,010,148.28267,530,319.93250,212,726.27
利润总额56,943,972.9633,063,815.15282,359,995.47254,980,079.52
净利润55,608,076.3329,779,054.03262,674,724.72223,329,538.72
每股收益
其他综合收益1,302,862.97-1,157,261.1610,988,800.8-4,248,904.58
综合收益总额56,910,939.328,621,792.87273,663,525.52219,080,634.14
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计1,857,744,984.161,721,424,797.371,824,194,344.461,798,075,174.43
非流动资产:
非流动资产合计1,797,528,836.641,866,516,898.971,880,920,162.341,765,123,689.86
资产总计3,655,273,820.83,587,941,696.343,705,114,506.83,563,198,864.29
流动负债:
流动负债合计604,777,563.3522,464,926.94667,437,831.62585,413,207.59
非流动负债:
非流动负债合计105,252,387.07102,226,151.51104,208,331.3697,381,710.63
负债合计710,029,950.37624,691,078.45771,646,162.98682,794,918.22
所有者权益(或股东权益):
归属于母公司股东权益合计2,952,110,239.822,970,496,731.952,939,828,873.182,888,835,756.7
股东权益合计2,945,243,870.432,963,250,617.892,933,468,343.822,880,403,946.07
负债和股东权益合计3,655,273,820.83,587,941,696.343,705,114,506.83,563,198,864.29
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计940,356,825.33415,715,171.281,990,421,560.11,536,103,915.7
经营活动现金流出小计844,070,909.74461,974,359.871,592,609,412.451,427,064,292.55
经营活动产生的现金流量净额96,285,915.59-46,259,188.59397,812,147.65109,039,623.15
投资活动产生的现金流量:
投资活动现金流入小计535,787,089.08173,477,532.061,012,007,594.1479,909,809.39
投资活动现金流出小计604,682,628.27266,143,555.311,539,117,843.7873,528,042.47
投资活动产生的现金流量净额-68,895,539.19-92,666,023.25-527,110,249.6-393,618,233.08
筹资活动产生的现金流量:
筹资活动现金流入小计2,694,000480,00032,081,058.4131,850,000
筹资活动现金流出小计68,733,899.7230,289,214.13128,500,100.06109,945,542.21
筹资活动产生的现金流量净额-66,039,899.72-29,809,214.13-96,419,041.65-78,095,542.21
汇率变动对现金及现金等价物的影响-390,807.3-39,862.028,121.71,154,988.32
现金及现金等价物净增加额-39,040,330.62-168,774,287.99-225,709,021.9-361,519,163.82
期末现金及现金等价物余额687,574,705.73557,840,748.36726,615,036.35590,804,894.43
补充资料:
现金及现金等价物的净增加额-39,040,330.62--225,709,021.9-
TOP↑